Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Sloan Sheldon
Chief Medical Officer at Spyre Therapeutics. Filing since 1 Apr 2026.
CIK 0002038798
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE
Spyre Therapeutics, Inc.
1 Jul 2026
Chief Medical Officer
Sold on a plan
8,334
$730.90K
100%
SYRE
Spyre Therapeutics, Inc.
3 Jun 2026
Chief Medical Officer
Sold on a plan
8,333
$624.98K
100%
SYRE
Spyre Therapeutics, Inc.
1 May 2026
Chief Medical Officer
Sold on a plan
78,333
$5.60M
100%
SYRE
Spyre Therapeutics, Inc.
1 Apr 2026
Chief Medical Officer
Sold on a plan
7,958
$397.90K
100%
4 decisions on file.
